Terray Therapeutics is a venture-backed biotechnology company that combines nanotechnology, experimental science, machine learning, and automation to transform small-molecule drug discovery and development. The company leverages its EMMI (Experimentation Meets Machine Intelligence) platform to power iterative cycles of molecular design and wet-lab experimentation, enabling rapid improvement in understanding biochemical interactions. Terray generates and learns from proprietary chemical data at scale to discover novel medicines, with an internal immunology pipeline and partnerships across multiple therapeutic areas. The company operates with deeply interconnected computational and experimental workflows where scientists and engineers collaborate to advance drug discovery.
Beta · Sourced from candidate reports
Be the first to share your experience with Terray Therapeutics.
Your reply helps other candidates know what to expect.
